Skip to Content
Merck

24023AST

Astec® CYCLOBOND I 2000 HP-RSP Chiral (5 μm) HPLC Columns

L × I.D. 15 cm × 4.6 mm, HPLC Column

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
15 cm × 4.6 mm
Particle size:
5 μm
Matrix active group:
cyclodextrin, beta- phase
Pore size:
100 Å
Matrix:
silica particle platform, fully porous particle
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

Astec® CYCLOBOND I 2000 HP-RSP Chiral HPLC Column, 5 μm particle size, L × I.D. 15 cm × 4.6 mm

material

stainless steel column

Quality Level

product line

Astec®

packaging

pkg of 1 ea

manufacturer/tradename

Astec®

parameter

0-50 °C temperature, 172 bar pressure (2500 psi)

technique(s)

HPLC: suitable, LC/MS: suitable

L × I.D.

15 cm × 4.6 mm

matrix

silica particle platform, fully porous particle

matrix active group

cyclodextrin, beta- phase

particle size

5 μm

pore size

100 Å

operating pH

3.5-7

separation technique

chiral

General description

In the design of this new chemistry, it was an objective to create a very stable and reproducible phase with shorter retention times, while maintaining or improving selectivity over CYCLOBOND I 2000 RSP. With that goal and more achieved, CYCLOBOND I 2000 HP-RSP separates by extended H-bonding capability, and offers broad chiral selectivity for chiral screening. It is most beneficial for basic and neutral compounds.

  • Bonded phase: (R,S)-Hydroxypropyl modified β-cyclodextrin (high performance)

Other Notes

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?




Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Assessment of the complexation degree of camptothecin derivatives and cyclodextrins using spectroscopic and separative methodologies
Foulon, C., et al.
Tetrahedron Asymmetry, 20 (21), 2482-2489 (2009)
Reprint of: Enantiomeric separation of functionalized ethano-bridged Troger bases using macrocyclic cyclofructan and cyclodextrin chiral selectors in high-performance liquid chromatography and capillary electrophoresis with application of principal component analysis
Weatherly, Choyce A., et al.
Journal of Chromatography. B, Biomedical Applications, 968, 40-48 (2014)
Roland Török et al.
Journal of chromatography. A, 1098(1-2), 75-81 (2005-11-30)
Direct high-performance liquid chromatographic methods were developed for the enantioseparation of (R,S)-bicalutamide (1) and its analogs (+/-)-3-chloro-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide (2), (+/-)-N-(4-cyano-3-(trifluoro-methyl)phenyl)-2-methyloxirane-2-carboxamide (3), (+/-)-4-fluorophenylsulfonyl-2-hydroxy-2-methylpropionic acid (4) and (+/-)-3-hydroxy-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide (5). The methods involved the use of a cellulose-based Chiralcel OD-H, macrocyclic glycopeptide-based Chirobiotic T